Artificial Intelligence: Page 5

Alverno Laboratories to expand Ibex’s AI-powered cancer diagnostics suite throughout its Midwest network

By LabPulse.com staff writers

Alverno, among the first U.S. laboratory networks to digitize its pathology services, is also the first to offer the Ibex AI-supported cancer diagnostic service in the U.S.

March 9, 2023

Viz.ai platform to be used in patient enrollment for pulmonary embolism trial

By LabPulse.com staff writers

Research institutions participating in the PE-TRACT trial will use the platform, Viz Recruit, to find, screen, and enroll trial candidates.

March 6, 2023

Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm

By LabPulse.com staff writers

The integrated Lunit Scope PD-L1 algorithm will augment the TissueNext test’s detection of the PD-L1 biomarker in tissue samples using an AI-based scoring system.

February 1, 2023

With Bill & Melinda Gates Foundation grant, VisualDx to develop diagnostic, surveillance tools for underserved

By LabPulse.com staff writers

The firm said it will use the funds to expand equitable access to its clinical decision support, artificial intelligence, and machine learning tools.

January 18, 2023

Paige joins forces with Microsoft on pathology AI

By LabPulse.com staff writers

Digital pathology company Paige is partnering with Microsoft on AI technology to develop clinical applications and computational biomarkers for digital pathology images to transform cancer diagnosis and patient care.

January 12, 2023

Avenda Health gets FDA 510(k) clearance for iQuest prostate cancer platform

By LabPulse.com staff writers

The iQuest platform provides physicians with a 3D visualization, enabling treatment decisions that consider the extent of the cancer rather than treating the whole organ.

December 8, 2022

PathomIQ presents data on AI predictive model at SABCS

By LabPulse.com staff writers

The model predicts the response to neoadjuvant chemotherapy in patients with triple-negative breast cancer through extracting morphological features.

December 8, 2022

Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform

By LabPulse.com staff writers

AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.

December 7, 2022

Klick Applied Sciences showcases study data demonstrating AI method for predicting diabetes

By LabPulse.com staff writers

Scientists from Klick Applied Sciences are developing a method of predicting diabetes by combining continuous glucose monitor technology with machine-learning models.

December 2, 2022

PreciseDx, Dordrecht Albert Schweitzer Hospital to evaluate cancer risk stratification platform

By LabPulse.com staff writers

The Laboratory of Pathology at Dordrecht, in the Netherlands, will study the performance of PreciseDx's artificial intelligence-based cancer risk stratification platform and test.

November 29, 2022

Deep Bio, Visiopharm collaborate on AI-based digital pathology for prostate cancer diagnosis

By LabPulse.com staff writers

The collaboration brings Deep Prostate AI software to Visiopharm’s European diagnostic customers, allowing pathologists to obtain an analysis of whole-slide images of H&E-stained biopsy tissue specimens.

November 15, 2022

AI-based diagnostics firm Ibex Medical Analytics secures $10M in financing

By LabPulse.com staff writers

Funding will also be used to accelerate research and development initiatives that focus on adding new applications to the company’s Galen platform.

November 9, 2022

Previous Page

Page 5 of 17

Next Page